Mayne Pharma Group Ltd has released a press release.
MYX signs license agreement for novel oral contraceptive
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- 2019 Full Year Results Investor Presentation
- 2019 Full Year Results Media Release
- 2019 Half Year Investor Presentation
- 2019 Half Year Media Release
- Half Year Accounts
Later from Mayne Pharma
- E4/DRSP contraceptive presented at EU gynecology conference
- 2019 AGM CEOs Speech
- 2020 Half Year Media Release
- 2020 Half Year Investor Presentation
- Mayne Pharma submits NDA for E4/DRSP to the FDA
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma